| Literature DB >> 33821309 |
P Niclas Broer1, Nicholas Moellhoff2, Thiha Aung3, Antonio J Forte4, Charlotte Topka1, Dirk F Richter5, Martin Colombo6, Sammy Sinno7, Andreas Kehrer3, Florian Zeman8, Rodney J Rohrich9, Lukas Prantl3, Paul I Heidekrueger10.
Abstract
BACKGROUND: Secondary breast reduction is complex and poses significant challenges to surgeons. Complication rates exceed those of primary reduction, commonly caused by impaired vascular supply of the nipple-areolar complex (NAC). Literature on the topic is scare and provides contradicting recommendations, especially with regard to pedicle choice in cases with unknown primary reduction technique. Aim of this study was to investigate international trends and to compare findings with literature.Entities:
Keywords: Breast re-reduction; Breast reduction; Mastopexy; Repeat reduction mammoplasty; Secondary mammoplasty
Mesh:
Year: 2021 PMID: 33821309 PMCID: PMC8677686 DOI: 10.1007/s00266-021-02243-1
Source DB: PubMed Journal: Aesthetic Plast Surg ISSN: 0364-216X Impact factor: 2.326
Overview of respondents’ years in practice across geographical regions.
| Years in practice | Total (% of respondents, | North America (% of respondents, n=221) | Latin America (% of respondents, n=430) | Europe (% of respondents, n=502) | Africa (% of respondents, n=39) | Middle East (% of respondents, n=97) | Central Asia (% of respondents, n=74) | South East Asia (% of respondents, n=32) | Oceania (% of respondents, n=36) |
|---|---|---|---|---|---|---|---|---|---|
| 0–5 | 5.5 | 0 | 6.0 | 6.2 | 10.3 | 10.3 | 8.1 | 0 | 5.6 |
| 6–10 | 10.0 | 2.7 | 14.0 | 9.0 | 10.3 | 18.6 | 10.8 | 6.3 | 0 |
| 11–15 | 15.8 | 16.3 | 16.3 | 14.3 | 20.5 | 18.6 | 18.9 | 12.5 | 11.1 |
| 16–20 | 18.0 | 10.0 | 18.4 | 22.5 | 15.4 | 12.4 | 21.6 | 15.6 | 11.1 |
| 21–25 | 17.1 | 25.3 | 12.1 | 14.9 | 17.9 | 21.6 | 9.5 | 28.1 | 50.0 |
| > 25 | 33.6 | 45.7 | 33.3 | 33.1 | 25.6 | 18.6 | 31.1 | 37.5 | 22.2 |
Overview of respondents’ type of practice across geographical regions.
| Type of practice | Total (% of respondents, n=1431) | North America (% of respondents, n=221) | Latin America (% of respondents, n=430) | Europe (% of respondents, n=502) | Africa (% of respondents, n=39) | Middle East (% of respondents, n=97) | Central Asia (% of respondents, n=74) | South East Asia (% of respondents, n=32) | Oceania (% of respondents, n=36) |
|---|---|---|---|---|---|---|---|---|---|
| Large plastic surgery practice (≥6 surgeons) | 8.1 | 2.7 | 7.0 | 11.2 | 5.1 | 7.2 | 12.2 | 12.5 | 5.6 |
| Small plastic surgery group (2–5 surgeons) | 24.7 | 17.2 | 26.5 | 31.5 | 10.3 | 16.5 | 12.2 | 31.3 | 11.1 |
| Solo | 43.0 | 58.8 | 44.2 | 31.5 | 64.1 | 48.5 | 44.6 | 43.8 | 50.0 |
| Solo practice–shared facility | 15.9 | 13.6 | 16.7 | 13.9 | 15.4 | 18.6 | 23.0 | 6.3 | 33.3 |
| Other (e.g., multispecialty group, academic, military):~multispeciality | 8.4 | 7.7 | 5.6 | 12.0 | 5.1 | 9.3 | 8.1 | 6.3 | 0 |
Overview of the relative amount of cosmetic and reconstructive procedures performed by the respondents across geographical regions.
| Nature of practice | Total (% of respondents, n=1431) | North America (% of respondents, n=221) | Latin America (% of respondents, n=430) | Europe (% of respondents, n=502) | Africa (% of respondents, n=39) | Middle East (% of respondents, n=97) | Central Asia (% of respondents, n=74) | South East Asia (% of respondents, n=32) | Oceania (% of respondents, n=36) |
|---|---|---|---|---|---|---|---|---|---|
| 100% cosmetic | 25.4 | 29.0 | 22.3 | 25.9 | 5.1 | 40.2 | 29.7 | 18.8 | 11.1 |
| 100% reconstructive | 2.0 | 2.7 | 1.9 | 2.4 | 0 | 0 | 0 | 0 | 5.6 |
| 25% cosmetic, 75% reconstructive | 15.0 | 12.7 | 9.3 | 22.1 | 35.9 | 1.0 | 14.9 | 25.0 | 5.6 |
| 50% cosmetic, 50% reconstructive | 19.0 | 22.6 | 18.1 | 16.5 | 33.3 | 17.5 | 16.2 | 3.1 | 50.0 |
| 75% cosmetic, 25% reconstructive | 38.6 | 33.0 | 48.4 | 33.1 | 25.6 | 41.2 | 39.2 | 53.1 | 27.8 |
Annual number of primary mammaplasties (mastopexy/ breast reduction) performed by respondents on an annual basis across geographical regions.
| Annual number of mastopexy/ breast reduction | Total (% of respondents, n=1431) | North America (% of respondents, n=221) | Latin America (% of respondents, n=430) | Europe (% of respondents, n=502) | Africa (% of respondents, n=39) | Middle East (% of respondents, n=97) | Central Asia (% of respondents, n=74) | South East Asia (% of respondents, n=32) | Oceania (% of respondents, n=36) |
|---|---|---|---|---|---|---|---|---|---|
| 1–50 | 64.3 | 52.9 | 67.7 | 65.7 | 79.5 | 55.7 | 73.0 | 84.4 | 44.4 |
| 51–150 | 31.0 | 39.8 | 28.1 | 31.1 | 15.4 | 42.3 | 21.6 | 3.1 | 38.9 |
| 151–250 | 3.6 | 4.5 | 2.8 | 2.4 | 5.1 | 2.1 | 5.4 | 12.5 | 16.7 |
| 251–350 | 0.8 | 1.8 | 1.4 | 0.4 | 0 | 0 | 0 | 0 | 0 |
| > 350 | 0.3 | 0.9 | 0 | 0.4 | 0 | 0 | 0 | 0 | 0 |
Fig. 1Balloon Plot depicting regional differences in the number of secondary mammaplasties performed, relative to the annual number of primary mastopexy/ breast reduction procedures. The distribution varied significantly across the geographical regions investigated (p<0.001)
Fig. 2Balloon Plot depicting regional differences in the choice of pedicle for secondary breast reduction if previous surgical technique was unknown. The preferred pedicle for secondary reductions differed significantly between regions (p<0.001)
Fig. 3Graphical residual analysis of pedicle choice depending on geographic region. Positive association between categories is indicated by blue color, negative association by red color. The size of the circle and transparency of the color refer to the strength of the association between the categories
Fig. 4Detailed citation attrition diagram depicting the search strategy
Overview of studies on secondary breast reduction and detailed study information
| Author [Ref] | Year | Location | Design | Patients (n) | Age (y) | Resection weight* (g) | First reduction (y previous) | FU (m) | Pedicle/ Procedure | Complications | Recommendation |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Lejour [ | 1997 | Belgium | Case-series | 10 | 42 | 289 | 8 | – | UP n=10 all Patients treated with vertical mammaplasty and superior pedicle | – | Vertical mammaplasty with superior pedicle is safe in secondary reduction; Liposuction is not contraindicated |
| Hudson [ | 1999 | South Africa | Case-series, retrospective analysis | 16 | 29 | 325 | 3 | >60 | IWE n=8 SP n=5 OP n=2 UP n=1 | MC n=3 NAC loss n=1, MC n=2 NAC loss n=1, congested NAC n=1 – | For NAC repositioning use SP; If unknown consider FNG; If NAC repositioning is not necessary, perform IWE |
| Losee [ | 2000 | USA | Case-series, retrospective review | 10 | 47 | 458 | 15 | 60 | SP n=3 OP n=7 | MC n=1 MC n=3 | Secondary reduction mammaplasty is safe with either similar or different technique. |
| Rohrich [ | 2003 | USA | Case-report, CME article | 2 | 42 | – | 16 | 6, 9 | Liposuction and IWE n=2 | – | Resection < 500g or Pseudoptosis: IWE; Resection >500g and NAC repositioning: SP if known, otherwise FNG |
| Patel [ | 2010 | USA | Case series, Viewpoint | 8 | 49 | 695 | 16 | – | SP n=3 OP n=5 | NAC necrosis n=1, major seroma/ abscess n=2 – | FNG for repeated bilateral reduction may be the technique of choice |
| Ahmad [ | 2012 - | Canada | Case series, retrospective review | 25 | 38 | 332 | 8 | 6 | SP n=9 OP n=2 UP n=11 all above patients treated with vertical scar reduction mammaplasty and de-epithelialized superior pedicle; IWE n=3 | – – – – – | Despite Wise pattern method for the primary breast reduction, vertical techniques for revisions are safe in secondary mammaplasty |
| Sultan [ | 2013 | USA | Case-series | 15 | 47 | 252 | 13 | – | OP n=4 UP n=11 all patients received vertical mammaplasties with superior and/or superomedial pedicles | MC n=1 – | Pseudoptosis: IWE; NAC repositioning: de-epithelialized superior pedicle + IWE; Liposuction as an adjunct |
| Mistry [ | 2017 - | New Zealand | Case series, retrospective review | 90 | 45 | 247 | 14 | 6 | IWE n=18 SP n=12 OP n=1 IWE +NAC de-epithelialization+ Lipo n=59 | – – MC n=1 MC n=1 | NAC elevation by de-epithelialization rather than using pedicle; Breast tissue removal using IWE + Liposuction; No skin excision horizontally below inframammary fold |
| Ghareeb [ | 2017 | USA | Case-series, retrospective review | 37 | – | 226 | 2 | – | SP n=26 breasts OP n=5 breasts UP n=4 breasts, IWE n=5 breasts | MC n=4 MC n=1 – – | A conservative superior or central mound pedicle can be used regardless of initial pedicle |
| Can 13] | 2018 | Turkey | Case-report | 1 | 48 | – | 13 | 3 | UP n=1 | – | For pseudoptosis IWE; For NAC elevations < 5 cm: superior pedicle and vertical reduction technique; Inverted-T-scar technique is not recommended; however, if required, perform horizontal skin excision superior to current scar |
| Spaniol [ | 2019 | USA | Retrospective cohort analysis | 30 | 40 | 464 | 9 | 5 | SP n=15 MCM reduction + SP n=5 IWE n=1 UP n=9 (vertical bipedicle n=1, superomedial n=1, IWE n=1, MCM n=6) | MC n=4 – – MC n=4 | If the primary pedicle is unknown, the MCM technique is an excellent option |
FNG Free nipple graft; FU Follow-Up; IWE Inferior Wedge Excision MC minor complications including delay in wound healing, delay in the return of nipple sensitivity, mild fat necrosis, minor necrosis areolar edge, dog-ear, small hematoma; MCM modified central mound (including superior and inferior pedicle); m months; NAC Nipple areolar complex; OP other pedicle as first reduction; Ref Reference; SP Same pedicle as first reduction; UP unknown pedicle; y years
*per breast